Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Marco Bechtel

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Cell Death Discovery|March 19, 2026
Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative propertiesDenisa Bojkova, Katja Steinhorst, Marco Bechtel, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 7, 2023
A Monoclonal Human Alveolar Epithelial Cell Line ("Arlo") with Pronounced Barrier Function for Studying Drug Permeability and Viral InfectionsPatrick Carius, Annemarie Jungmann, Marco Bechtel, et al.
Journal of Medical Virology|March 10, 2023
Repurposing of the antibiotic nitroxoline for the treatment of mpoxDenisa Bojkova, Nadja Zöller, Manuela Tietgen, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trialOlha Holubovska, Denisa Bojkova, Stefano Elli, et al.
Iscience|January 16, 2023
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platformDenisa Bojkova, Philipp Reus, Leona Panosch, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Cell Death Discovery|March 19, 2026
Discovery of synthetic G-quadruplex DNA as SARS-CoV-2 helicase inhibitor with antiviral, anti-inflammatory and antioxidative propertiesDenisa Bojkova, Katja Steinhorst, Marco Bechtel, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|February 7, 2023
A Monoclonal Human Alveolar Epithelial Cell Line ("Arlo") with Pronounced Barrier Function for Studying Drug Permeability and Viral InfectionsPatrick Carius, Annemarie Jungmann, Marco Bechtel, et al.
Journal of Medical Virology|March 10, 2023
Repurposing of the antibiotic nitroxoline for the treatment of mpoxDenisa Bojkova, Nadja Zöller, Manuela Tietgen, et al.
Medrxiv : the Preprint Server for Health Sciences|January 20, 2021
Enisamium is an inhibitor of the SARS-CoV-2 RNA polymerase and shows improvement of recovery in COVID-19 patients in an interim analysis of a clinical trialOlha Holubovska, Denisa Bojkova, Stefano Elli, et al.
Iscience|January 16, 2023
Identification of novel antiviral drug candidates using an optimized SARS-CoV-2 phenotypic screening platformDenisa Bojkova, Philipp Reus, Leona Panosch, et al.
Pageof 2